| Autor: |
van der Straten L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Blijlevens NMA; Department of Haematology, Radboud University Medical Center, Nijmegen, The Netherlands., Cornelissen JJ; Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Doorduijn JK; Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kater AP; Department of Haematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Haematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. |
Plný text